Here are five things to know:
1. Before the acquisition, Avalign partnered with RoundTable Healthcare Partners.
2. Avalign manufactures implants and instruments, specialty instrumentation, cutting tools and cases and trays for orthopedic medical device and specialty surgical markets. The company provides manufacturing solutions, engineering design and development to its OEM partners.
3. Arlington Capital’s investment funds represent more than $1.5 billion of committed capital, with a focus on middle market investment opportunities on healthcare services, among other industries.
4. Arlington Partner, Matt Altman, praised the Avalign management team and said the company is an “established leader in the large and growing orthopedic precision manufacturing market.”
5. The exact terms of the agreement, including the cost of acquisition, were not disclosed.
More articles on devices:
Lucideon adds impingement testing: 5 things to know
25 spine devices receive FDA 510(k) clearance in June
St. Jude Medical receives FDA approval for wireless spinal cord stimulation: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
